Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000144·Cellectar Biosciences, Inc.
Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common Stock · CUSIP: 15117F807
Event date: 2024-12-31
- Filing-level shares
- 3,955,470.00
- Percent of class
- 8.8%
- LYTTON LAURENCE W
Shares: 3,955,470.00 · Class: 8.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000144
- Form type
- SCHEDULE 13G/A
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership